This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lock, J. E. Articles by Fellows, K. E. Search for Related Content PubMed PubMed Citation Articles by Lock, J. E. Articles by Fellows, K. E.

Circulation, Vol 75, 593-599, Copyright © 1987 by American Heart Association

ARTICLES

Transcatheter umbrella closure of congenital heart defects

JE Lock, JT Cockerham, JF Keane, JP Finley, PE Wakely Jr and KE Fellows

Between October 1984 and September 1986, we attempted transcatheter umbrella closure, using the Rashkind PDA occluder, of 12 congenital or postoperative cardiovascular defects (other than patent ductus arteriosus [PDA]) in 11 patients. In each, we used the umbrella for closure because the defect was too short and/or too large to close with conventional transcatheter methods. The defects included three post- Glenn venous communications (superior vena cava-right atrium, n = 2; azygos vein to inferior vena cava), four congenital "interatrial defects" producing cyanosis ("coronary sinus" septal defect, left superior vena cava to left atrium, patent foramen ovale, left inferior vena cava to left atrium), and five non-PDA systemic-to-pulmonary arterial communications (two congenital and three postoperative). Ten of 12 defects were embolized successfully; nine had complete or subtotal closure, and one was partially closed. The first attempted closure resulted in embolization of a 12 mm device to a lower-lobe pulmonary artery, without clinical sequelae. No other complications occurred. Clinical improvement was most dramatic in those patients whose cyanosis was relieved and less obvious when pulmonary blood flow was reduced. The Rashkind umbrella device, originally designed for closure of PDA, considerably expands the list of congenital or operative defects that can be closed nonsurgically.

This article has been cited by other articles:

				L. Hongxin, S. Lijun, Z.-j. Wang, J. Zi, W.-l. Zhang, H.-z. Zhang, G. Wenbin, and C.-w. Zou Intraoperative device closure of large secundum atrial septal defects; a safe alternative to transcatheter closure Eur. J. Cardiothorac. Surg., June 1, 2008; 33(6): 1055 - 1060. [Abstract] [Full Text] [PDF]

				A. W. Nugent, A. Britt, K. Gauvreau, G. E. Piercey, J. E. Lock, and K. J. Jenkins Device Closure Rates of Simple Atrial Septal Defects Optimized by the STARFlex Device J. Am. Coll. Cardiol., August 1, 2006; 48(3): 538 - 544. [Abstract] [Full Text] [PDF]

				G. Fischer, H.H. Kramer, J. Stieh, P. Harding, and O. Jung Transcatheter closure of secundum atrial septal defects with the new self-centering Amplatzer Septal Occluder Eur. Heart J., April 1, 1999; 20(7): 541 - 549. [Abstract] [PDF]

				C Rickers, C Hamm, H Stern, T Hofmann, O Franzen, R Schräder, H Sievert, D Schranz, I Michel-Behnke, J Vogt, et al. Percutaneous closure of secundum atrial septal defect with a new self centring device ("angel wings") Heart, November 1, 1998; 80(5): 517 - 521. [Abstract] [Full Text]

				R. G. Grifka, C. E. Mullins, C. Gianturco, M. R. Nihill, M. P. O'Laughlin, M. C. Slack, F. J. Clubb, and T. J. Myers New Gianturco-Grifka Vascular Occlusion Device : Initial Studies in a Canine Model Circulation, March 15, 1995; 91(6): 1840 - 1846. [Abstract] [Full Text]